Drawing for FINCERAMICA

USPTO serial 79411542

FINCERAMICA

Reviewed by CopyMark Law Group

Reg. 8278820Status 700Registered
Filing date
Status date
Registration date
Jun 2, 2026
Examiner
PAINTER, VALERIYA SHERMAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FINCERAMICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

N. Alexander Nolte

N. Alexander Nolte Nolte Lackenbach Siegel111 Brook Street, Suite 101Scarsdale, NY 10583United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and biomedical products, namely, pharmaceutical preparations for tissue regeneration, namely, for bone regeneration and for treating bone defects and osteochondral lesions; regenerative medicine products, namely, pharmaceutical preparations for wound treatment; genetically engineered tissue comprising living tissue for medical transplant purposes; tissue comprising living tissue for medical purposes combined with the use of cells or pharmaceutical preparations; preparations for medical and veterinary purposes, namely, pharmaceutical preparations for wound treatment; sanitary preparations for medical use; cements for dental prostheses; dental composite materials; dental restoration compounds; embedding material for dental use, namely, dental composite materials; dental resins; synthetic resins for use in dentistry; surgical implants comprised of living tissues; transplants comprising living tissues; bone void fillers comprised of living tissues; cells for medical use; biological implants, namely, surgical implants comprised of living tissues; surgical implants comprising living tissue grown from stem cells; teeth filling materialACTIVE—
010Synthetic implantable medical devices for medical-surgical use, namely, devices for chondral or osteochondral lesions, traumatology, arthroplasty revision, implantable device in orthopedic, spinal, dental surgery, bone cavity filling, cranioplasty; implantable medical devices made from artificial substances for veterinary use, namely, implants made of artificial materials for veterinary use; synthetic implantable medical devices for the regeneration of bone defects; synthetic implantable medical devices for the regeneration of cartilaginous defects; synthetic implantable medical devices for the regeneration of osteocartilagineous defects; artificial filling materials for augmentation of bone tissue; synthetic bone substitutes for surgical use; synthetic bone substitute for surgical and orthopaedic purposes; artificial implantable medical devices for the reconstruction of bone, cartilage or osteocartilage in orthopedic, spinal, dental, cranio-maxillo-facial surgery; orthopedic prostheses; implantable prosthetic devices of artificial material for joints; implantable prosthetic devices made from artificial substances for cranioplasty; non-implantable medical devices for creating surgical joint defects through arthrotomic or minimally invasive arthrotomic approaches; non-implantable medical devices for perfusion and mixing of biological fluids and filling materials; medical materials being medical materials and medical devices for tissue engineering, combined with use of cells or pharmaceutical drugs, namely, implantable chondral or osteochondral scaffolds primarily comprised of synthetic materialsACTIVE—
035On-line retail store services of pharmaceuticals and biomedical products, regenerative medicine products, tissue engineering products, dental amalgams and cements, dental grafts and implants, implantable medical devices, bone and tooth reconstruction materials, medical materials and medical devices for tissue engineering; retail store and wholesale store services of pharmaceuticals and biomedical products, regenerative medicine products, tissue engineering products, dental amalgams and cements, dental grafts and implants, implantable medical devices, bone and tooth reconstruction materials, medical materials and medical devices for tissue engineering; marketing services; advertising services; presentation of pharmaceutical and biomedical products, regenerative medicine products, tissue engineering products, dental amalgams and cements, grafts and implants for dental use, implantable medical devices, bone and tooth reconstruction materials, medical materials and medical devices for tissue engineering by means of retail media being retail store services featuring pharmaceutical and biomedical products, regenerative medicine products, tissue engineering products, dental amalgams and cements, grafts and implants for dental use, implantable medical devices, bone and tooth reconstruction materials, medical materials and medical devices for tissue engineering; event management services being arranging, namely, organizing and conducting of marketing promotional eventsACTIVE—
041Organization and management being conducting of training workshops in the field of Cranial, Orthopedic, Maxillo-Facial and Spinal Surgery; training courses in the field of Cranial, Orthopedic, Maxillo-Facial and Spinal Surgery; remote surgical training in the field of Cranial, Orthopedic, Maxillo-Facial and Spinal Surgery provided via smart devices; training services through digital platforms providing courses of instruction in the field of medicine via a website; operator training services providing workshops and training for doctors, agents and distributors in the field of surgical activities; operator training services providing workshops, training, and live surgery demonstrations for doctors, agents and distributors in the field of surgical activities in the field of dental, orthopedic, neurosurgical implants; training academies featuring non-downloadable webinars, masterclasses, and training services in the field of Cranial, Orthopedic, Maxillo-Facial and Spinal Surgery; publication of manuals; training and support being courses of instruction in the use of surgical instruments and apparatus; training and support being courses of instruction in the use of dental, orthopedic, neurosurgical implant systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 2, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 2, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 21, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 4, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 4, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 14, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 14, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 19, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 19, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 19, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 19, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 19, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2025RFNTREFUSAL PROCESSED BY IB—
Sep 5, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 5, 2025RFRRREFUSAL PROCESSED BY MPU—
Aug 1, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 31, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 31, 2025DOCKASSIGNED TO EXAMINER—
Jul 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 30, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance